title: The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa.
abstract: OBJECTIVE
  To document the influence of HIV status on drug reactions occurring in patients on antituberculous therapy in Harare, Zimbabwe.
  
  
  METHODS
  Retrospective cohort study.
  
  
  METHODS
  City of Harare Tuberculosis Unit.
  
  
  METHODS
  Records of 906 patients with tuberculosis, of whom 162 reacted to antituberculous therapy, were analysed.
  
  
  RESULTS
  Reactions to antituberculous drugs were more frequent in HIV-positive (98 out of 363) than in HIV-negative (64 out of 543; P less than 0.0001) patients. The most common drug reaction was cutaneous hypersensitivity, occurring in 139 patients, 89 (64%) of whom were HIV-positive. Thiacetazone was implicated in 115 (82.7%) of the 139 cutaneous reactions and streptomycin in 10 (7.2%). Almost all cutaneous reactions occurred within 8 weeks of beginning treatment. Severe cutaneous reactions occurred more often in HIV-positive patients (P less than 0.001) and the only two deaths occurred in this group. Reactions to multiple drugs occurred in 18 HIV-positive and three HIV-negative patients (P = 0.017).
  
  
  CONCLUSIONS
  The use of thiacetazone and streptomycin in antituberculous drug regimens should be reassessed in those countries where coinfection with HIV and tuberculosis is common.
authors.affiliation: Department of Medicine, University of Zimbabwe, Harare.
authors.forename: A L
authors.initials: AL
authors.lastname: Pozniak
authors.forename: G A
authors.initials: GA
authors.lastname: MacLeod
authors.forename: M
authors.initials: M
authors.lastname: Mahari
authors.forename: W
authors.initials: W
authors.lastname: Legg
authors.forename: J
authors.initials: J
authors.lastname: Weinberg
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects*; D015331:Cohort Studies; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013307:Streptomycin / Q000009:adverse effects; D013828:Thioacetazone / Q000009:adverse effects; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*; D015030:Zimbabwe
chemical_list: D000995:Antitubercular Agents; D013828:Thioacetazone; D013307:Streptomycin